In vitro studies and RNA sequencing have identified aberrations in the MAPK pathway, which encompasses the RAS-RAF-MEK signaling cascade, in MCC cell lines [37,38,39]. This evidence concerns the gene MAP2K7 and Merkel cell skin cancer.